摘要: An Introduction to Epigenetics, M. Esteller Epigenetics and Cancer: DNA Methylation, S. Ropero Histone Modifications, M.F. Fraga Epigenetic Drugs: Demethylating Agents, E. Atallah G. Garcia-Manero Deacetylase Inhibitors, Peart R.W. Johnstone Sirtuins in Biology Disease, A. Vaquero D. Reinberg microRNAs Cell Diseases, Fabbri, C. Croce, Calin Chromatin Modifications by Polycomb Complexes, Vidal its Genetic Syndromes, R.J. Gibbons Immunity, Ballestar B. Richardson Etiology of Major Psychosis: Why Do We Need Epigenetics?, Oh Petronis Cardiovascular Lund Zaina Plant Meijon, L. Valledor, J.L. Rodriguez, R. Hasbun, Santamaria, I. Feito, M.J. Canal, Berdasco, Fraga, Rodriguez Environment, Evolution, D.M. Ruden, P. Rasouli, X. Lu Epigenomics, J.I. Martin-Subero Siebert
sci-hub.st 参考文章(208)
GJ Dover, S Charache, SH Boyer, G Vogelsang, M Moyer, 5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens Blood. ,vol. 66, pp. 527- 532 ,(1985) , 10.1182/BLOOD.V66.3.527.527
G. Schwartsmann, H. Schunemann, C.N.F. Gorini, A.F. Ferreira Filho, C. Garbino, G. Sabini, I. Muse, L DiLeone, D.R. Mans, A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer. Investigational New Drugs. ,vol. 18, pp. 83- 91 ,(2000) , 10.1023/A:1006388031954
Melanie Ehrlich, DNA alterations in cancer : genetic and epigenetic changes Eaton Publishing. ,(2000)
George Wilding, Howard Bailey, Mary B. Tombes, Mary B. Tombes, Dona Alberti, Dona Alberti, Rhoda Z. Arzoomanian, Rhoda Z. Arzoomanian, Joan Bruggink, Joan Bruggink, Kendra D. Tutsch, Kendra D. Tutsch, Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion Cancer Research. ,vol. 51, pp. 1105- 1108 ,(1991)
Donald E Olins, Ada L Olins, Granulocyte heterochromatin: defining the epigenome BMC Cell Biology. ,vol. 6, pp. 39- 39 ,(2005) , 10.1186/1471-2121-6-39
Nicholas J. Vogelzang, James E. Herndon, Constance Cirrincione, David C. Harmon, Karen H. Antman, Joseph M. Corson, Yasunosuke Suzuki, Marc L. Citron, Mark R. Green, , Dihydro-5-azacytidine in malignant mesothelioma : A phase II trial demonstrating activity accompanied by cardiac toxicity Cancer. ,vol. 79, pp. 2237- 2242 ,(1997) , 10.1002/(SICI)1097-0142(19970601)79:11<2237::AID-CNCR23>3.0.CO;2-W
F Sorm, J Vesely, THE ACTIVITY OF A NEW ANTIMETABOLITE, 5-AZACYTIDINE, AGAINST LYMPHOID LEUKAEMIA IN AK MICE. Neoplasma. ,vol. 11, pp. 123- ,(1964)
Philip Avner, Edith Heard, X-chromosome inactivation: counting, choice and initiation Nature Reviews Genetics. ,vol. 2, pp. 59- 67 ,(2001) , 10.1038/35047580
A. Aparicio, C. A. Eads, L. A. Leong, P. W. Laird, E. M. Newman, T. W. Synold, S. D. Baker, M. Zhao, J. S. Weber, Phase I trial of continuous infusion 5-aza-2'-deoxycytidine. Cancer Chemotherapy and Pharmacology. ,vol. 51, pp. 231- 239 ,(2003) , 10.1007/S00280-002-0563-Y
Mark Schrader, Jana Sachsinger, Markus Müller, Hans Krause, Rüdiger Heicappell, Kurt Miller, Carsten Goessl, Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Research. ,vol. 60, pp. 5941- 5945 ,(2000)